Skip to content

In the BioHarmony Drug Report Database

Alglucosidase alfa

Lumizyme, Myozyme (alglucosidase alfa) is an enzyme pharmaceutical. Alglucosidase alfa was first approved as Lumizyme on 2006-03-28. It is used to treat glycogen storage disease type II in the USA. It has been approved in Europe to treat glycogen storage disease type II.
Trade Name Myozyme
Common Name Alglucosidase alfa
Indication glycogen storage disease type ii
Drug Class Enzymes
Alglucosidase alfa
Get full access now